Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Apollo Health Ventures is a transatlantic early-stage venture capital firm founded in 2017. The firm operates from offices in Berlin, Luxembourg, and Boston, focusing on co-founding and investing in healthcare companies that target age-related diseases and aging. Apollo Health Ventures has raised a total of $180 million for its second fund, which closed in December 2021. This fund aims to support 10 to 15 companies, emphasizing the importance of biotechnology in addressing healthspan and chronic diseases.
The firm employs a distinctive venture lab model, partnering with leading scientists to develop innovative healthcare solutions while also investing in external early-stage ventures. Apollo Health Ventures has established a strong track record since its inception, co-founding companies like Samsara Therapeutics, which focuses on autophagy-enhancing therapies. The firm’s commitment to advancing human health is evident in its strategic investments and partnerships across North America and Europe.
Apollo Health Ventures invests primarily in early-stage healthcare companies that develop novel interventions aimed at preserving health and preventing age-associated decline and chronic diseases. The firm targets sectors such as biotechnology and healthcare, with a specific emphasis on therapeutics that address age-related diseases like Alzheimer's, cancer, and neurodegenerative conditions. Investment stages range from pre-seed to Series A, allowing the firm to engage with startups at various points in their development.
The firm’s investment strategy is rooted in the belief that biotechnology is a primary driver of change and economic value in healthcare, particularly in the context of aging populations. Apollo Health Ventures seeks to partner with strong founders and breakthrough science, providing not only capital but also scientific and operational expertise to ensure the success of its portfolio companies. The firm’s approach includes a hands-on model that emphasizes team building and access to resources, enhancing the potential for growth and innovation.
Apollo Health Ventures has a diverse portfolio of companies focused on addressing age-related diseases and enhancing healthspan. Notable portfolio companies include:
This portfolio reflects Apollo Health Ventures' commitment to investing in companies that leverage biotechnology to address significant health challenges associated with aging.
Nils Regge: Co-Founder & General Partner. Nils is recognized as one of Europe's most successful serial entrepreneurs, bringing extensive experience in building and scaling companies in the biotech sector.
Dr. Ole Mensching: Co-Founder & General Partner. Dr. Mensching has a strong background in life sciences and venture capital, contributing to the firm's strategic direction.
Dr. Marianne Mertens: Partner. Dr. Mertens has over 13 years of experience in the life sciences industry, previously working with Wellington Partners and High-Tech Gründerfonds.
Antoine Boulanger, Ph.D.: Partner. Antoine specializes in venture capital and has a deep understanding of the biotech landscape.
Dr. Alexandra Bause: Co-Founder & Venture Partner. Dr. Bause brings expertise in scientific research and company formation.
Florian Haupt: Partner. Florian has a strong background in investment and operational management within the healthcare sector.
Anne Marije van Harten, Ph.D.: Investment Director. Anne Marije focuses on identifying and evaluating investment opportunities in the biotech space.
Chris Shepard, Ph.D.: Venture Partner. Chris has extensive experience in scientific research and venture capital.
Dr. Steven Leunert: Partner & CFO. Dr. Leunert oversees financial operations and strategic planning for the firm.
Marcel Behringer: General Counsel. Marcel provides legal guidance and support for the firm's investments.
Michelle Hohmann: Senior HR Manager & Recruiter. Michelle focuses on talent acquisition and organizational development.
Lia Goedecke: Senior Recruiter. Lia supports recruitment efforts for portfolio companies.
Pascale Eede, Ph.D.: Associate. Pascale assists in investment analysis and due diligence.
Dr. Gerd Hummel: Venture Partner. Dr. Hummel brings expertise in scientific research and company formation.
Dr. Jens Eckstein: Advisor. Dr. Eckstein has over 25 years of experience in biotech venture capital.
Dr. Jeanne Bolger: Advisor. Dr. Bolger provides strategic insights and guidance to the firm.
Rob Scott, MD: Advisor. Dr. Scott offers expertise in clinical strategy and healthcare innovation.
To pitch to Apollo Health Ventures, founders should use the preferred channel of their website at apollo.vc or email info@apollo.vc. A comprehensive pitch deck is essential, including details about the business model, market opportunity, and team qualifications.
Founders should expect a response within a few weeks, depending on the volume of inquiries. Warm introductions can enhance the chances of securing a meeting, so leveraging connections within the biotech and healthcare sectors is advisable.
Apollo Health Ventures operates a venture lab that partners with leading scientists and research institutes to build transformative healthcare companies. This program focuses on co-founding companies that leverage scientific advancements to create innovative solutions for age-related diseases.
Eligibility for participation in the venture lab typically includes having a strong scientific foundation and a viable business model. Interested parties can apply through the firm's website or by contacting them directly for more information.
In December 2021, Apollo Health Ventures closed its second fund at $180 million, aimed at supporting innovative companies in the healthcare sector. This fund is expected to target 10 to 15 companies, focusing on age-related diseases and biotechnology.
Recently, Apollo Health Ventures has been active in co-founding and investing in companies like Samsara Therapeutics, which is recognized as the world's largest autophagy platform. The firm continues to expand its portfolio, reflecting its commitment to addressing significant health challenges associated with aging.
What are Apollo Health Ventures' investment criteria?
Apollo Health Ventures focuses on early-stage healthcare companies that develop innovative solutions for age-related diseases. They prioritize biotechnology and seek startups with strong founders and breakthrough science.
How can I apply or pitch to Apollo Health Ventures?
Founders can pitch their ideas through the firm's website at apollo.vc or by emailing info@apollo.vc. A detailed pitch deck should be included, outlining the business model, market opportunity, and team.
What makes Apollo Health Ventures different from other VCs?
The firm operates a unique venture lab model, co-founding companies with leading scientists and providing hands-on support in scientific and operational areas. This approach allows for a deeper integration of expertise and resources.
What is the geographic scope of Apollo Health Ventures?
Apollo Health Ventures invests in companies across North America and Europe, focusing on the transatlantic market for healthcare innovation.
What is the typical check size for investments?
While specific check sizes are not disclosed, Apollo Health Ventures targets early-stage investments, which typically range from pre-seed to Series A funding rounds.
What kind of post-investment involvement can portfolio companies expect?
Apollo Health Ventures provides ongoing support to its portfolio companies, including access to scientific expertise, operational guidance, and follow-on capital to help scale their businesses effectively.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.